Geisinger Medical Laboratories Test Catalog
EBV NUCLEAR ANTIGEN IGG ANTIBODY |
|||||||||
ORDERING INFORMATION: |
Geisinger Epic Procedure Code: LAB2232 Geisinger Epic ID: 7431 | ||||||||
SPECIMEN COLLECTION |
|||||||||
Specimen type: |
Serum | ||||||||
Preferred collection container: |
|||||||||
Alternate Collection Container: |
6 mL red-top (plain, non-serum separator) tube
|
||||||||
Specimen required: |
0.5 mL serum; minimum 0.2 mL | ||||||||
SPECIMEN PROCESSING |
|||||||||
Specimen processing instructions: |
Allow to clot. Centrifuge and submit 0.5 mL serum. | ||||||||
Transport temperature: |
Refrigerated (preferred). Room temperature (stable 8 hours) or frozen specimen also acceptable. | ||||||||
Specimen stability: |
Room temperature: 8 hours. 2-8°C: 96 hours. Frozen: 6 months | ||||||||
Rejection criteria: |
Specimen stability exceeded; specimen grossly hemolyzed. | ||||||||
TEST DETAILS |
|||||||||
Interpretation guide: |
|
||||||||
CPT code(s): |
86664 | ||||||||
Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | |||||||||
Test includes: |
ualitativ | ||||||||
Methodology: |
Chemiluminescence |
||||||||
Synonyms: |
EBNA, Epstein Barr IgG antibody to nuclear antigens Epstein Barr Nuclear Antigen, Epstein Barr Virus EBV-EBNA, EBNAAB, EBV Serology, EBNA, EBV Antibody EBNA IgG Antibody, Epstein Barr Nuclear Antigen IgG
|
||||||||
Clinical significance: |
Epstein-Barr virus (EBV) is responsible for infectious mononucleosis (IM) and has also been implicated in Burkitt's lymphoma and nasopharyngeal carcinoma. EBV-NA (Epstein-Barr virus nuclear antigen) IgG antibodies appear during the convalescent phase of IM and remain present throughout life. A positive EBV-NA IgG antibody in a healthy individual indicates past immunological exposure to EBV. | ||||||||
Doctoral Director(s:) |
Hoi-Ying Elsie Yu PhD, DABCC, FADLM | ||||||||
Review Date: | 12/13/2022 |